2024 Q4 Form 10-Q Financial Statement

#000149315224043700 Filed on November 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $128.0K
YoY Change 341.38%
Cost Of Revenue $54.00K
YoY Change 980.0%
Gross Profit $74.00K
YoY Change 208.33%
Gross Profit Margin 57.81%
Selling, General & Admin $2.113M
YoY Change -25.86%
% of Gross Profit 2855.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $273.0K
YoY Change -51.25%
% of Gross Profit 368.92%
Operating Expenses $2.440M
YoY Change -28.53%
Operating Profit -$2.312M
YoY Change -31.8%
Interest Expense $301.0K
YoY Change 37.44%
% of Operating Profit
Other Income/Expense, Net $347.0K
YoY Change -329.8%
Pretax Income -$1.965M
YoY Change -44.49%
Income Tax
% Of Pretax Income
Net Earnings -$1.965M
YoY Change -47.02%
Net Earnings / Revenue -1535.16%
Basic Earnings Per Share -$3.82
Diluted Earnings Per Share -$3.82
COMMON SHARES
Basic Shares Outstanding 993.1K shares 145.6M shares
Diluted Shares Outstanding 710.1K shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.59M
YoY Change 1594.78%
Cash & Equivalents $10.52M
Short-Term Investments $5.077M
Other Short-Term Assets $233.0K
YoY Change -41.75%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $15.83M
YoY Change 1100.68%
LONG-TERM ASSETS
Property, Plant & Equipment $192.0K
YoY Change 392.31%
Goodwill
YoY Change
Intangibles $184.0K
YoY Change 89.69%
Long-Term Investments
YoY Change
Other Assets $259.0K
YoY Change 0.0%
Total Long-Term Assets $6.312M
YoY Change -6.49%
TOTAL ASSETS
Total Short-Term Assets $15.83M
Total Long-Term Assets $6.312M
Total Assets $22.14M
YoY Change 174.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $956.0K
YoY Change -64.67%
Accrued Expenses $2.252M
YoY Change 8.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $20.00K
YoY Change -99.23%
Total Short-Term Liabilities $3.903M
YoY Change -53.85%
LONG-TERM LIABILITIES
Long-Term Debt $103.0K
YoY Change -26.43%
Other Long-Term Liabilities $102.0K
YoY Change -43.33%
Total Long-Term Liabilities $205.0K
YoY Change -35.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.903M
Total Long-Term Liabilities $205.0K
Total Liabilities $4.108M
YoY Change -53.23%
SHAREHOLDERS EQUITY
Retained Earnings -$183.7M
YoY Change 6.34%
Common Stock $1.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $18.03M
YoY Change
Total Liabilities & Shareholders Equity $22.14M
YoY Change 174.38%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.965M
YoY Change -47.02%
Depreciation, Depletion And Amortization $273.0K
YoY Change -51.25%
Cash From Operating Activities -$1.651M
YoY Change -14.46%
INVESTING ACTIVITIES
Capital Expenditures $143.0K
YoY Change 257.5%
Acquisitions
YoY Change
Other Investing Activities -$4.968M
YoY Change
Cash From Investing Activities -$5.111M
YoY Change 16936.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 80.00K
YoY Change -112.5%
NET CHANGE
Cash From Operating Activities -1.651M
Cash From Investing Activities -5.111M
Cash From Financing Activities 80.00K
Net Change In Cash -6.682M
YoY Change 157.0%
FREE CASH FLOW
Cash From Operating Activities -$1.651M
Capital Expenditures $143.0K
Free Cash Flow -$1.794M
YoY Change -8.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38834
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-7122000 usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
259000 usd
CY2024Q3 us-gaap Assets
Assets
22137000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
956000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2252000 usd
CY2024Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
360000 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
20000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
75000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3903000 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
103000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
102000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
4108000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7218000 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001566610
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
usd
CY2024Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
usd
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
usd
us-gaap Interest Income Other
InterestIncomeOther
usd
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
CY2024Q3 VERB Financing Costs
FinancingCosts
usd
CY2023Q3 VERB Financing Costs
FinancingCosts
usd
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
usd
CY2023Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
usd
CY2024Q3 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
usd
CY2023Q3 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
usd
us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
usd
VERB Stock Issued During Period Value Redeemed In Exchange For Common Shares
StockIssuedDuringPeriodValueRedeemedInExchangeForCommonShares
usd
VERB Deemed Dividend Dues To Warrant Reset
DeemedDividendDuesToWarrantReset
usd
VERB Stock Issued During The Period Value Issuance Of Shares For Fractional Adjustments Related To Reverse Stock Split
StockIssuedDuringThePeriodValueIssuanceOfSharesForFractionalAdjustmentsRelatedToReverseStockSplit
usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
usd
VERB Fair Value Of Common Shares Issued To Redeem Series C Preferred Shares
FairValueOfCommonSharesIssuedToRedeemSeriesCPreferredShares
usd
VERB Fair Value Of Common Shares Issued To Settle Accrued Expenses
FairValueOfCommonSharesIssuedToSettleAccruedExpenses
usd
VERB Derecognition Of Operating Lease Right Of Use Assets
DerecognitionOfOperatingLeaseRightOfUseAssets
usd
VERB Derecognition Of Operating Lease Liabilities
DerecognitionOfOperatingLeaseLiabilities
usd
VERB Derecognition Of Other Assets And Liabilities Related To Lease Termination
DerecognitionOfOtherAssetsAndLiabilitiesRelatedToLeaseTermination
usd
VERB Recognition Of Operating Lease Rightofuse Asset And Related Lease Liability
RecognitionOfOperatingLeaseRightofuseAssetAndRelatedLeaseLiability
usd
VERB Discount Recognized From Advances On Future Receipts
DiscountRecognizedFromAdvancesOnFutureReceipts
usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
usd
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
usd
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
usd
CY2024Q3 VERB Finite Lived Intangible Assets Amortization Expense Year Four And Thereafter
FiniteLivedIntangibleAssetsAmortizationExpenseYearFourAndThereafter
usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
usd
CY2024Q3 VERB Lessee Operating Lease Liability Payments Due Year Four And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter
usd
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
usd
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
CY2024Q3 VERB Notes Payable Related Parties Debt Discount
NotesPayableRelatedPartiesDebtDiscount
usd
CY2024Q3 VERB Notes Payable Related Parties Debt Issuance Costs
NotesPayableRelatedPartiesDebtIssuanceCosts
usd
CY2024Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2024Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
usd
CY2024Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
usd
CY2024Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2023Q4 VERB Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
VERB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
VERB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q3 VERB Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Registrant Name
EntityRegistrantName
Verb Technology Company, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-1118043
dei Entity Address Address Line1
EntityAddressAddressLine1
3024 Sierra Juniper Court
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89138
dei City Area Code
CityAreaCode
(855)
dei Local Phone Number
LocalPhoneNumber
250-2300
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
dei Trading Symbol
TradingSymbol
VERB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
993071 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2024Q3 us-gaap Cash
Cash
10515000 usd
CY2023Q4 us-gaap Cash
Cash
4353000 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
5077000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
233000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
331000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
15825000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
4684000 usd
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3242000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3990000 usd
CY2024Q3 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
2263000 usd
CY2023Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1528000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
192000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
172000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
218000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
184000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
117000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
259000 usd
CY2023Q4 us-gaap Assets
Assets
10839000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1408000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2324000 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
420000 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
648000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1787000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
533000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
67000 usd
CY2024Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
240000 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7188000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
362000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
164000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
7714000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
763230 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
763230 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
106157 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
106157 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
200788000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
175766000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-183655000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-175622000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
18029000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3125000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22137000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10839000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
128000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
172000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34000 usd
CY2024Q3 VERB Cost Of Revenue Exclusive Of Depreciation And Amortization
CostOfRevenueExclusiveOfDepreciationAndAmortization
54000 usd
CY2023Q3 VERB Cost Of Revenue Exclusive Of Depreciation And Amortization
CostOfRevenueExclusiveOfDepreciationAndAmortization
5000 usd
VERB Cost Of Revenue Exclusive Of Depreciation And Amortization
CostOfRevenueExclusiveOfDepreciationAndAmortization
90000 usd
VERB Cost Of Revenue Exclusive Of Depreciation And Amortization
CostOfRevenueExclusiveOfDepreciationAndAmortization
7000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
273000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
564000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
798000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1730000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2113000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2850000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9080000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
2440000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
3419000 usd
us-gaap Operating Expenses
OperatingExpenses
8106000 usd
us-gaap Operating Expenses
OperatingExpenses
10817000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2312000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3390000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-7934000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10783000 usd
CY2024Q3 us-gaap Interest Income Other
InterestIncomeOther
193000 usd
us-gaap Interest Income Other
InterestIncomeOther
361000 usd
CY2024Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
109000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
109000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
219000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
236000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
989000 usd
VERB Financing Costs
FinancingCosts
90000 usd
VERB Financing Costs
FinancingCosts
1239000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
46000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
64000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
648000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
844000 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
4000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
210000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
347000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-151000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
793000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1174000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1965000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3541000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7141000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-11957000 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-168000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1965000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3709000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7141000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19079000 usd
CY2024Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
99000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
240000 usd
CY2024Q3 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
652000 usd
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
652000 usd
us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
164000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2716000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3709000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8033000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19243000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.82
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.82
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-130.64
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-130.64
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-17.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-17.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-516.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-516.80
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-6.20
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-6.20
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-303.66
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-303.66
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
710106 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
710106 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27104 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27104 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
468252 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
468252 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23454 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23454 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3125000 usd
us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
18596000 usd
VERB Stock Issued During The Fair Value Of Vested Restricted Stock Awards Stock Options And Warrants
StockIssuedDuringTheFairValueOfVestedRestrictedStockAwardsStockOptionsAndWarrants
822000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
2867000 usd
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
240000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7141000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
18029000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5166000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5166000 usd
us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
6628000 usd
VERB Stock Issued During The Fair Value Of Vested Restricted Stock Awards Stock Options And Warrants
StockIssuedDuringTheFairValueOfVestedRestrictedStockAwardsStockOptionsAndWarrants
1932000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
200000 usd
VERB Stock Issued During Period Value Fair Value Of Common Shares Issued To Settle Accrued Expenses
StockIssuedDuringPeriodValueFairValueOfCommonSharesIssuedToSettleAccruedExpenses
346000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4092000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19079000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-715000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-715000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7141000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19079000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-7122000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
798000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1730000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
958000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1985000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
99000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
238000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
73000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
182000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
210000 usd
VERB Finance Costs
FinanceCosts
-90000 usd
VERB Finance Costs
FinanceCosts
-1239000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
109000 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
263000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
39000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-52000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
46000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
170000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-13000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
735000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-887000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
265000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-53000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-63000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6901000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6619000 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1855000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
239000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
5103000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
135000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
182000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
84000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
14000 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5234000 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-275000 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
4750000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18596000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6628000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
105000 usd
us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
180000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
14000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
383000 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
18297000 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4855000 usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-2367000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6162000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1511000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4353000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2429000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10515000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
918000 usd
VERB Revenue Fee Percentage
RevenueFeePercentage
0.25 pure
CY2023Q2 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
6500000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
4750000 usd
CY2023Q2 us-gaap Discontinued Operation Amounts Of Material Contingent Liabilities Remaining
DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining
1750000 usd
CY2024Q3 us-gaap Cash
Cash
10515000 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
5077000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_zmic4RUfDhh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zs1IWsCti9T7">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reported periods. Significant estimates include assumptions made in analysis of assumptions made in purchase price allocations, impairment testing of long-term assets, realization of deferred tax assets, determining fair value of derivative liabilities, and valuation of equity instruments issued for services. Some of those assumptions can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions or conditions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
VERB Revenue Fee Percentage
RevenueFeePercentage
0.25 pure
us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p id="xdx_84E_eus-gaap--DerivativesReportingOfDerivativeActivity_z7c796HDYnSb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zfEVqKdV0GG9">Derivative Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses Level 2 inputs for its valuation methodology for the derivative liabilities as their fair values were determined by using a Binomial pricing model. The Company’s derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjusted to fair value of derivatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 VERB Remaining Warrants Shares Delisted
RemainingWarrantsSharesDelisted
879 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zyh8PnnK5VE5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zgtYTRF1H1F1">Concentration of Credit and Other Risks</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and accounts receivable. Cash is deposited with a limited number of financial institutions. The balances held at any one financial institution at times may be in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits of up to $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20240930_zxP0UdN8QJSg" title="Cash FDIC">250</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s concentration of credit risk includes its concentrations from key customers and vendors. The details of these significant customers and vendors are presented in the following table for the nine months ended September 30, 2024 and 2023:</span></p> <p id="xdx_897_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zT9OGSx0TlTd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zeterUWYkICe">SCHEDULE OF CONCENTRATION RISK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Nine Months Ended September 30,</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2024</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2023</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">The Company’s largest customers are presented below as a percentage of the aggregate</span></td><td><span style="font-size: 10pt"> </span></td> <td><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 32%"><span style="font-size: 10pt">Revenues</span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 32%; text-align: center"><span style="font-size: 10pt">Two customers accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenuesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zi0w90HD8QAa">41</span></span><span style="font-size: 10pt">% of revenues</span></td><td style="width: 2%"><span style="font-size: 10pt"> </span></td> <td style="width: 32%; text-align: center"><span style="font-size: 10pt">No customers individually over <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenuesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zxqLHG2PaHj2" title="Revenues and purchases">10</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt">The Company’s largest vendors are presented below as a percentage of the aggregate</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Purchases</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt">One vendor accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zqrTxxJW4Zne" title="Revenues and purchases">18</span>% of its purchases individually and in the aggregate</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt">One vendor accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zPhqWNbrw9K9" title="Revenues and purchases">28</span>% of its purchases individually and in the aggregate</span></td></tr> </table> <p id="xdx_8AF_zEfg7YED917c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
us-gaap Interest Paid Net
InterestPaidNet
4000 usd
us-gaap Interest Paid Net
InterestPaidNet
242000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2000 usd
VERB Fair Value Of Common Shares Issued As Payment On Notes Payable
FairValueOfCommonSharesIssuedAsPaymentOnNotesPayable
2777000 usd
VERB Fair Value Of Common Shares Issued As Payment On Notes Payable
FairValueOfCommonSharesIssuedAsPaymentOnNotesPayable
4092000 usd
VERB Fair Value Of Common Shares Issued To Redeem Series C Preferred Shares
FairValueOfCommonSharesIssuedToRedeemSeriesCPreferredShares
2737000 usd
VERB Fair Value Of Common Shares Issued To Settle Accrued Expenses
FairValueOfCommonSharesIssuedToSettleAccruedExpenses
346000 usd
VERB Derecognition Of Operating Lease Right Of Use Assets
DerecognitionOfOperatingLeaseRightOfUseAssets
1186000 usd
VERB Derecognition Of Operating Lease Liabilities
DerecognitionOfOperatingLeaseLiabilities
1870000 usd
VERB Derecognition Of Other Assets And Liabilities Related To Lease Termination
DerecognitionOfOtherAssetsAndLiabilitiesRelatedToLeaseTermination
421000 usd
VERB Recognition Of Operating Lease Rightofuse Asset And Related Lease Liability
RecognitionOfOperatingLeaseRightofuseAssetAndRelatedLeaseLiability
245000 usd
VERB Discount Recognized From Advances On Future Receipts
DiscountRecognizedFromAdvancesOnFutureReceipts
558000 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
5077000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4968000 usd
us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
109000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
5077000 usd
CY2024Q3 us-gaap Marketable Securities
MarketableSecurities
5077000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3990000 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
6176000 usd
CY2023 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
23000 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
748000 usd
CY2023 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
2209000 usd
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3242000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3990000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
250000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
998000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
997000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
997000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3242000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
68000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
121000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.090 pure
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.090 pure
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
172000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
218000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
75000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
67000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
102000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
164000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
177000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
231000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
24000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
96000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
75000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
195000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
18000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
177000 usd
CY2023Q2 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
6500000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
4750000 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
5441000 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-168000 usd
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
3814000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-7122000 usd
CY2023Q4 VERB Notes Payable Related Parties Debt Discount
NotesPayableRelatedPartiesDebtDiscount
-99000 usd
CY2023Q4 VERB Notes Payable Related Parties Debt Issuance Costs
NotesPayableRelatedPartiesDebtIssuanceCosts
-73000 usd
CY2024Q3 us-gaap Notes Payable
NotesPayable
123000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
2149000 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
103000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
362000 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
20000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1787000 usd
CY2024Q2 VERB Shares Issued At Discount Stated Percentage
SharesIssuedAtDiscountStatedPercentage
0.10 pure
CY2024Q2 VERB Loss On Issue Of Shares At Discount
LossOnIssueOfSharesAtDiscount
90000 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
75000 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
55000 usd
CY2024Q3 VERB Interest Income Expense Other
InterestIncomeExpenseOther
1000 usd
CY2023Q3 VERB Interest Income Expense Other
InterestIncomeExpenseOther
89000 usd
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-219000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
99000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
238000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
73000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
182000 usd
VERB Interest Income Expense Other
InterestIncomeExpenseOther
64000 usd
VERB Interest Income Expense Other
InterestIncomeExpenseOther
569000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-236000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-989000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
210000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
240000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
767 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1176.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
197 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1499.74
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
14 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
8480.00
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
556 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
867.17
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10435 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
240.14
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1397 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
306.75
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9038 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
229.83
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4900 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
243.74
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y10M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
4900 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
243.74
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y10M6D
CY2024Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
100000 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
529000 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
904000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0462 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0429 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.392 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.362 pure
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
4598 shares
CY2023Q4 VERB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
6752.00
CY2023 VERB Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms Beginning
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsBeginning
P3Y1M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
1053 shares
VERB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeited In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice
24098.44
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
3545 shares
CY2024Q3 VERB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
1769.64
VERB Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms Beginning
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsBeginning
P3Y2M4D
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2720.00
CY2023Q1 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
1600.00
CY2023Q1 VERB Deemed Dividend Due To Warrant Reset
DeemedDividendDueToWarrantReset
164000 usd
CY2024Q2 VERB Remaining Warrants Shares Delisted
RemainingWarrantsSharesDelisted
879 shares
CY2024Q3 us-gaap Other Commitment
OtherCommitment
300000 usd
CY2023Q3 us-gaap Litigation Settlement Interest
LitigationSettlementInterest
584000 usd
CY2023Q3 VERB Counsel Fee
CounselFee
8000 usd
VERB Board Fees Expense
BoardFeesExpense
501000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
128000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
54000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
5000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
273000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
564000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2113000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2850000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
2440000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
3419000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2312000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3390000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
172000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34000 usd
us-gaap Cost Of Revenue
CostOfRevenue
90000 usd
us-gaap Cost Of Revenue
CostOfRevenue
7000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
798000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1730000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7218000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9080000 usd
us-gaap Operating Expenses
OperatingExpenses
8106000 usd
us-gaap Operating Expenses
OperatingExpenses
10817000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-7934000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10783000 usd
CY2024Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
reverse stock split in the range within a range of one-for-five (1-for-5) to a maximum of a one-for-two hundred (1-for-200)
CY2024Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 200 reverse stock split
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-24-043700-index-headers.html Edgar Link pending
0001493152-24-043700-index.html Edgar Link pending
0001493152-24-043700.txt Edgar Link pending
0001493152-24-043700-xbrl.zip Edgar Link pending
ex10-1.htm Edgar Link pending
ex10-2.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
verb-20240930.xsd Edgar Link pending
verb-20240930_cal.xml Edgar Link unprocessable
verb-20240930_def.xml Edgar Link unprocessable
verb-20240930_lab.xml Edgar Link unprocessable
verb-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable